Skip to search formSkip to main contentSkip to account menu

Aurora Kinase Inhibitor BI 811283

Known as: BI 811283 
A small molecule inhibitor of the serine/threonine protein kinase Aurora kinase with potential antineoplastic activity. Aurora kinase inhibitor BI… 
National Institutes of Health

Related topics

Related topics

1 relation
Aurora Kinase A

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
A phase I dose-escalation study of BI 811283, an Aurora B inhibitor, administered days 1 and 15, every four weeks in patients with advanced solid tumors.
e13065 Background: BI 811283 has demonstrated potent antitumor activity in cancer models at well-tolerated doses, with hallmarks… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)